 |
|
Polymyositis and Penicillamine
Paul L. Schraeder, MD;
Henry A. Peters, MD;
David S. Dahl, MD
Arch Neurol. 1972;27(5):456-457.
Abstract
A 23-year-old asymptomatic woman, known to be homozygous for Wilson's disease, developed polymyositis while receiving prophylactic penicillamine. Symptoms abated when penicillamine was discontinued. Possible effects of penicillamine on immune mechanisms are discussed. The symptoms of Wilson's disease and polymyositis may be difficult to differentiate.
Author Affiliations
Madison, Wis
From the University of Wisconsin Medical Center, Department of Neurology, Madison.
Footnotes
Accepted for publication June 20, 1972.
Reprint requests to Department of Neurology. 1954 E Washington Ave, Madison, Wis 53704 (Dr. Peters).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Postural changes, dysphagia, and systemic sclerosis
Barrera et al.
Ann Rheum Dis 1998;57:331-338.
FULL TEXT
Factors Modifying the Prognosis of Wilson's Disease in Childhood
Kudo and Arima
J Child Neurol 1987;2:57-62.
ABSTRACT
Fatal Polymyositis in D-Penicillamine-Treated Rheumatoid Arthritis
DOYLE et al.
ANN INTERN MED 1983;98:327-330.
ABSTRACT
Adverse Effects of D-Penicillamine in Rheumatoid Arthritis
STEIN et al.
ANN INTERN MED 1980;92:24-29.
ABSTRACT
D-Penicillamine and Lupus Erythematosuslike Syndrome
HARKCOM et al.
ANN INTERN MED 1978;89:1012-1012.
ABSTRACT
D-Penicillamine-Induced Polymyositis in Rheumatoid Arthritis
CUCHER and GOLDMAN
ANN INTERN MED 1976;85:615-616.
ABSTRACT
Monoclonal Gammopathy Penicillamine-Induced Polymyositis and Systemic Sclerosis
Nishikai et al.
Arch Dermatol 1974;110:253-255.
ABSTRACT
DOUBT WILSON DISEASE: To the Editor.
Scheinberg
Arch Neurol 1973;29:449-449.
ABSTRACT
|
